EP Patent

EP4380570A1 — Compositions and methods for the treatment of opioid overdose

Assigned to Indivior Inc · Expires 2024-06-12 · 2y expired

What this patent protects

Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising nalmefene are provided. Methods of treating opioid overdose with the drug products are also provided.

USPTO Abstract

Drug products adapted for nasal delivery, comprising a pre-primed device filled with a pharmaceutical composition comprising nalmefene are provided. Methods of treating opioid overdose with the drug products are also provided.

Drugs covered by this patent

Patent Metadata

Patent number
EP4380570A1
Jurisdiction
EP
Classification
—
Expires
2024-06-12
Drug substance claim
No
Drug product claim
No
Assignee
Indivior Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.